title: Biomarker-guided de-escalation of empirical therapy is associated with lower risk for adverse outcomes.
authors.affiliation: Medical University Department, Kantonsspital Aarau, Tellstrasse, 5001, Aarau, Switzerland, schuetzph@gmail.com.
authors.forename: Philipp
authors.initials: P
authors.lastname: Schuetz
authors.forename: Beat
authors.initials: B
authors.lastname: Mueller
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D018805:Sepsis / Q000188:drug therapy*; D012772:Shock, Septic / Q000401:mortality*
chemical_list: D000900:Anti-Bacterial Agents